Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.0268 | 0.6688 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0268 | 0.6688 | 0.6293 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0218 | 0.4803 | 0.5 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0356 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0227 | 0.5125 | 0.5125 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0268 | 0.6688 | 0.6293 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0218 | 0.4803 | 0.4803 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0356 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0227 | 0.5125 | 0.4543 |
Brugia malayi | Protein kinase domain containing protein | 0.0268 | 0.6688 | 0.6688 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0356 | 1 | 1 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0218 | 0.4803 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0268 | 0.6688 | 0.6688 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0218 | 0.4803 | 0.4803 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0268 | 0.6688 | 0.6293 |
Echinococcus granulosus | proteasome prosome macropain | 0.0218 | 0.4803 | 0.4182 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0218 | 0.4803 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.0268 | 0.6688 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0218 | 0.4803 | 0.6646 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0268 | 0.6688 | 0.6688 |
Mycobacterium ulcerans | proteasome PrcB | 0.0218 | 0.4803 | 0.5 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0356 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0268 | 0.6688 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0218 | 0.4803 | 0.6646 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0218 | 0.4803 | 0.5 |
Brugia malayi | Kringle domain containing protein | 0.0268 | 0.6688 | 0.6688 |
Brugia malayi | Trypsin family protein | 0.0227 | 0.5125 | 0.5125 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0218 | 0.4803 | 0.6646 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0227 | 0.5125 | 0.4543 |
Onchocerca volvulus | 0.0268 | 0.6688 | 0.5221 | |
Loa Loa (eye worm) | hypothetical protein | 0.0227 | 0.5125 | 0.5125 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.0356 | 1 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.012 | 0.1067 | 0.1067 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0218 | 0.4803 | 0.4182 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0218 | 0.4803 | 0.6646 |
Onchocerca volvulus | 0.0227 | 0.5125 | 0.2964 | |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0268 | 0.6688 | 1 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0218 | 0.4803 | 0.4182 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0218 | 0.4803 | 1 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0268 | 0.6688 | 1 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0218 | 0.4803 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.